Evaluation of Protective Potential of Yersinia pestis Outer Membrane Protein Antigens as Possible Candidates for a New-Generation Recombinant Plague Vaccine

Plague caused by Yersinia pestis manifests itself in bubonic, septicemic, and pneumonic forms. Although the U.S. Food and Drug Administration recently approved levofloxacin, there is no approved human vaccine against plague. The capsular antigen F1 and the low-calcium-response V antigen (LcrV) of Y....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Erova, Tatiana E., Rosenzweig, Jason A., Sha, Jian, Suarez, Giovanni, Sierra, Johanna C., Kirtley, Michelle L., van Lier, Christina J., Telepnev, Maxim V., Motin, Vladimir L., Chopra, Ashok K.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2013
Assuntos:
Vaccines
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3571283/
https://ncbi.nlm.nih.gov/pubmed/23239803
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00597-12
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados